Why the study?
Does immunosuppression with cortisone and cyclosporine improve outcomes in a patient with fulminant myocarditis and gene expression pattern of giant cell myocarditis?
Does immunosuppression with cortisone and cyclosporine improve outcomes in a patient with fulminant myocarditis and gene expression pattern of giant cell myocarditis?
Immunosuppression with cortisone and cyclosporine, guided by gene expression profiling, may be effective in fulminant myocarditis even without histological confirmation of giant cells.
Hypothesis-generating for gene expression-guided immunosuppression in fulminant myocarditis; prospective trials needed before adoption.
A healthy woman with acute onset of pulmonary oedema and severely depressed left ventricular function underwent endomyocardial biopsy under the clinical suspicion of fulminant myocarditis. While awaiting the results of biopsy, the situation deteriorated to Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) and extracorporeal membrane oxygenation was implanted. Finally, immunohistochemistry in biopsy specimen corresponded to fulminant lymphocytic myocarditis, although active myocarditis was excluded. Furthermore, gene expression profiling identified giant cell myocarditis although multinuclear cells were absent. This prompted the start of immunosuppression with cortisone and cyclosporine. The patient fully recovered.
No takes yet. Share an insight, caveat, or question.
Fruhwald et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: